These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20575190)

  • 1. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician attitudes toward industry: a view across the specialties.
    Korenstein D; Keyhani S; Ross JS
    Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 4. New Swiss guidelines aim to curb big pharma's influence.
    Hyde R
    Lancet; 2013 Feb; 381(9865):441-2. PubMed ID: 23405415
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
    Cicero MX; Curi MB; Mercurio M
    Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflict of interest: the elephant in your practice.
    Kaliski S
    Afr J Psychiatry (Johannesbg); 2013 May; 16(3):161, 163, 165. PubMed ID: 23739815
    [No Abstract]   [Full Text] [Related]  

  • 7. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
    Ichikawa I; Clayton EW
    Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
    [No Abstract]   [Full Text] [Related]  

  • 8. How to get full, meaningful disclosure.
    Moynihan R
    Med J Aust; 2011 Nov; 195(10):571. PubMed ID: 22106995
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry relationships with physicians under scrutiny.
    Beller GA
    J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
    [No Abstract]   [Full Text] [Related]  

  • 10. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thanks, but no thanks.
    Bell H
    Minn Med; 2008 Apr; 91(4):26-30. PubMed ID: 18549004
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of expediency.
    Glickel SZ
    J Hand Surg Am; 2009; 34(5):799-807. PubMed ID: 19410982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunshine Has Darkened my Worldview.
    Alward WL
    Am J Ophthalmol; 2017 Mar; 175():xii-xiii. PubMed ID: 28088286
    [No Abstract]   [Full Text] [Related]  

  • 15. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 16. No more free lunches.
    Abbasi K; Smith R
    BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 18. Compliance: what you need to know.
    Evans GRD; Haeck P; Roth M; McGuire M; Glasberg S; Wells J; Costelloe M; Stokes M; Wargo C
    Plast Reconstr Surg; 2011 Nov; 128(5):1143-1148. PubMed ID: 22030493
    [No Abstract]   [Full Text] [Related]  

  • 19. US campaign aims to end industry gifts, speaking fees, and travel for doctors.
    Tanne JH
    BMJ; 2007 Feb; 334(7590):385. PubMed ID: 17322228
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.